187 related articles for article (PubMed ID: 8611711)
21. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease.
Knecht H; Berger C; McQuain C; Rothenberger S; Bachmann E; Martin J; Esslinger C; Drexler HG; Cai YC; Quesenberry PJ; Odermatt BF
Oncogene; 1999 Nov; 18(50):7161-7. PubMed ID: 10597317
[TBL] [Abstract][Full Text] [Related]
22. HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin's lymphoma.
Diepstra A; Poppema S; Boot M; Visser L; Nolte IM; Niens M; Te Meerman GJ; van den Berg A
Tissue Antigens; 2008 Mar; 71(3):219-26. PubMed ID: 18257895
[TBL] [Abstract][Full Text] [Related]
23. Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implications for cytotoxic T-lymphocyte control of EBV-associated malignancies.
Khanna R; Burrows SR; Moss DJ; Silins SL
J Virol; 1996 Aug; 70(8):5357-62. PubMed ID: 8764046
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus association in classical Hodgkin's disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed-Sternberg cells.
Naresh KN; Johnson J; Srinivas V; Soman CS; Saikia T; Advani SH; Badwe RA; Dinshaw KA; Muckaden M; Magrath I; Bhatia K
Ann Oncol; 2000 Jan; 11(1):91-6. PubMed ID: 10690394
[TBL] [Abstract][Full Text] [Related]
25. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
[TBL] [Abstract][Full Text] [Related]
26. Frequent lack of translation of antigen presentation-associated molecules MHC class I, CD1a and Beta(2)-microglobulin in Reed-Sternberg cells.
Van den Berg A; Visser L; Eberwine J; Dadvand L; Poppema S
Int J Cancer; 2000 May; 86(4):548-52. PubMed ID: 10797270
[TBL] [Abstract][Full Text] [Related]
27. bcl-2 expression in Hodgkin's disease. Correlation with the t(14;18) translocation and Epstein-Barr virus.
Bhagat SK; Medeiros LJ; Weiss LM; Wang J; Raffeld M; Stetler-Stevenson M
Am J Clin Pathol; 1993 May; 99(5):604-8. PubMed ID: 8388163
[TBL] [Abstract][Full Text] [Related]
28. Variable expression of Epstein-Barr virus latent membrane protein I in Reed-Sternberg cells of Hodgkin's disease.
Teramoto N; Cao L; Kawasaki N; Tonoyama Y; Sarker AB; Yoshino T; Takahashi K; Akagi T
Acta Med Okayama; 1996 Oct; 50(5):267-70. PubMed ID: 8914680
[TBL] [Abstract][Full Text] [Related]
29. Reappraisal of the relationship between immunoglobulin heavy chain gene rearrangement and Epstein-Barr virus infection in Reed-Sternberg cells of Hodgkin's disease.
Mikata A; Li DX; Kurosu K; Oda K; Yumoto N; Tamaru JI
Leuk Lymphoma; 1997 Dec; 28(1-2):145-52. PubMed ID: 9498713
[TBL] [Abstract][Full Text] [Related]
30. Phenotype of Hodgkin and Sternberg-Reed cells and expression of CD57 (LEU7) antigen.
Papadimitriou CS; Bai MK; Kotsianti AJ; Costopoulos JS; Hytiroglou P
Leuk Lymphoma; 1995 Dec; 20(1-2):125-30. PubMed ID: 8750633
[TBL] [Abstract][Full Text] [Related]
31. Association of Hodgkin's lymphoma with Epstein Barr virus infection.
Cickusić E; Mustedanagić-Mujanović J; Iljazović E; Karasalihović Z; Skaljić I
Bosn J Basic Med Sci; 2007 Feb; 7(1):58-65. PubMed ID: 17489771
[TBL] [Abstract][Full Text] [Related]
32. Demonstration by single-cell PCR that Reed--Sternberg cells and bystander B lymphocytes are infected by different Epstein--Barr virus strains in Hodgkin's disease.
Faumont N; Al Saati T; Brousset P; Offer C; Delsol G; Meggetto F
J Gen Virol; 2001 May; 82(Pt 5):1169-1174. PubMed ID: 11297691
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus in Hodgkin's disease: more than just an innocent bystander.
Oudejans JJ; Jiwa NM; Meijer CJ
J Pathol; 1997 Apr; 181(4):353-6. PubMed ID: 9196428
[TBL] [Abstract][Full Text] [Related]
34. Absence of HLA class I expression by Reed-Sternberg cells.
Poppema S; Visser L
Am J Pathol; 1994 Jul; 145(1):37-41. PubMed ID: 7518195
[TBL] [Abstract][Full Text] [Related]
35. High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin's disease occurring in Peru.
Chang KL; Albújar PF; Chen YY; Johnson RM; Weiss LM
Blood; 1993 Jan; 81(2):496-501. PubMed ID: 8380728
[TBL] [Abstract][Full Text] [Related]
36. Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology.
Knecht H; McQuain C; Martin J; Rothenberger S; Drexler HG; Berger C; Bachmann E; Kittler EL; Odermatt BF; Quesenberry PJ
Oncogene; 1996 Sep; 13(5):947-53. PubMed ID: 8806684
[TBL] [Abstract][Full Text] [Related]
37. Pathophysiology of Hodgkin's disease: functional and molecular aspects.
Gruss HJ; Kadin ME
Baillieres Clin Haematol; 1996 Sep; 9(3):417-46. PubMed ID: 8922238
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease.
Roskrow MA; Suzuki N; Gan Yj; Sixbey JW; Ng CY; Kimbrough S; Hudson M; Brenner MK; Heslop HE; Rooney CM
Blood; 1998 Apr; 91(8):2925-34. PubMed ID: 9531603
[TBL] [Abstract][Full Text] [Related]
39. Hodgkin's disease in Costa Rica: a report of 40 cases analyzed for Epstein-Barr virus.
Monterroso V; Zhou Y; Koo S; Glackin C; Bujan W; Medeiros LJ
Am J Clin Pathol; 1998 May; 109(5):618-24. PubMed ID: 9576582
[TBL] [Abstract][Full Text] [Related]
40. Molecular single-cell analysis of the clonal relationship of small Epstein-Barr virus-infected cells and Epstein-Barr virus-harboring Hodgkin and Reed/Sternberg cells in Hodgkin disease.
Spieker T; Kurth J; Küppers R; Rajewsky K; Bräuninger A; Hansmann ML
Blood; 2000 Nov; 96(9):3133-8. PubMed ID: 11049994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
